UMMC Launches Genetic-Testing Program for Cardiac Stent Patients

May 14, 2013

New personalized medicine initiative enables doctors to tailor drug therapies to individual patients based on genetic profile

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center now can receive long-term therapy based on information found in their genes. As part of a new personalized medicine initiative, the medical center is offering genetic testing to help doctors determine which medication a patient should take after a stenting procedure in order to prevent blood clots that could lead to serious and potentially fatal heart attacks and strokes.

To read the full news release, click here.